The United Nations Industrial Development Organization (UNIDO) highlighted Cuba science’s ability to develop four anti-COVID-19 vaccine candidates, among them Soberana 02, soon to enter Phase III trials and bound to be the first Latin American vaccine against the SARS-CoV-2 virus.

The ingenuity and will of good health professionals reflect on every service of the Maria Curie Oncology Hospital in this city, amid the increasing restrictions of the U.S. economic, commercial and financial blockade on Cuba and the current COVID-19 pandemic.

 The Cuban biotechnological and pharmaceutical industry company ( Biocen) has the capacity for the large-scale production of anti-COVID-19 vaccines.

Cuban Nephrology Institute Doctor Abelardo Buch Lopez, in Havana, is carrying out 32 research projects aimed at branches of the specialty such as chronic kidney disease, dialysis, transplantation, clinical nephrology and pathology.

 The Center for Industrial Biotechnology ( CEBI), of the University of Oriente in Santiago de Cuba(esatern country), is leading modern biotechnological research in Cuba aimed at the use of microorganisms and biomolecules for the sustainable development of agriculture, health, food production, industry and the protection of the environment.

Cuba studied 19,322 samples for COVID-19, resulting in 580 positive ones. The country accumulates 2,049,708 samples taken and 34,064 positive ones.

HAVANA, Cuba, Feb 9 (ACN) Starting February 15, an epidemiological monitoring system developed by the company Datys will be implemented in the Cuban capital to make results of PCR tests available in the shortest possible time.

Cuba studied 18,981 samples for COVID-19, resulting in 653 positive ones. The country accumulates 2,030,386 samples tested and 33,484 positive.

Senior personalities of the Serbian Academy of Sciences and Arts reported today that they sent a document to the Norwegian Nobel Committee with detailed arguments in support of the nomination of Cuba's Henry Reeve International Medical Brigade for the 2021 Nobel Peace Prize.

Cuba reported today 845 new positive cases of COVID-19, a figure that confirms that the country remains with a significant epidemiological complexity.

Dental services are among the public health services most affected nowadays by the tightening of the economic, commercial and financial blockade imposed by the United States on Cuba almost six decades ago.

 Cuba studied for COVID-19, 18,017 samples resulting in 845 positive ones. The country accumulates 1,976,118 samples taken and 31,190 positive.

Doctor of Science Vicente Vérez Bencomo, general director of the Finlay Vaccine Institute (IFV), announced that in April they should produce the first million vaccines against COVID-19 from that center, which will allow expanding their application and demonstrating with more evidence their efficacy.

The Center for Genetic Engineering and Biotechnology (CIGB) expects to advance in March to Phase III of the clinical trials of the Abdala vaccine candidate (CIGB-66), after more than 300 individuals participated in the second stage of its short vaccination scheme.